CollPlant Biotechnologies annual operating expenses
2017
2018
2019
2020
2021
2022
2023
2024
2025
CollPlant Biotechnologies Operating Expenses Growth & History (CLGN)
CollPlant Biotechnologies's operating expenses was $13.0M for fiscal 2025.
View full CollPlant Biotechnologies company overviewCollPlant Biotechnologies annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $13.0M | −$3.1M | −19.34% |
| 2024 | 2024-12-31 | $16.1M | −$339,000 | −2.06% |
| 2023 | 2023-12-31 | $16.5M | −$516,000 | −3.04% |
| 2022 | 2022-12-31 | $17.0M | $3.4M | +25.24% |
| 2021 | 2021-12-31 | $13.6M | $13.5M | +39814.71% |
| 2020 | 2020-12-31 | $34,000 | −$3.3M | −98.97% |
| 2019 | 2019-12-31 | $3.3M | $1.1M | +51.51% |
| 2018 | 2018-12-31 | $2.2M | −$4.2M | −65.79% |
| 2017 | 2017-12-31 | $6.4M | — | — |
CollPlant Biotechnologies quarterly operating expenses
Q2.18
Q2.19
Q2.20
Q2.21
Q2.22
Q2.23
Q2.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
| Fiscal quarter | Period ended | Operating expenses | Change | YoY change |
|---|---|---|---|---|
| Q1 2026 | 2026-03-31 | $2.9M | −$643,000 | −18.29% |
| Q4 2025 | 2025-12-31 | $3.0M | — | — |
| Q3 2025 | 2025-09-30 | $3.3M | — | — |
| Q2 2025 | 2025-06-30 | $3.2M | −$948,000 | −23.02% |
| Q1 2025 | 2025-03-31 | $3.5M | — | — |
| Q2 2024 | 2024-06-30 | $4.1M | $227,000 | +5.83% |
| Q2 2023 | 2023-06-30 | $3.9M | −$316,000 | −7.51% |
| Q2 2022 | 2022-06-30 | $4.2M | $883,000 | +26.56% |
| Q2 2021 | 2021-06-30 | $3.3M | $1.3M | +67.25% |
| Q2 2020 | 2020-06-30 | $2.0M | $247,000 | +14.19% |
| Q2 2019 | 2019-06-30 | $1.7M | $237,000 | +15.76% |
| Q2 2018 | 2018-06-30 | $1.5M | — | — |
CollPlant Biotechnologies operating expenses trends
Over the last five fiscal years, CollPlant Biotechnologies's operating expenses increased from $34,000 to $13.0M, a change of $13.0M. The latest reported quarter, Q1 2026, shows $2.9M.
About the metric
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
Calculation and source
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review CollPlant Biotechnologies source filings ↗